CorMatrix ECM for Vascular Repair
DeviceStandard femoral arterial interventional procedure using CorMatrix ECM for vascular repair.
NCT Number: NCT02418156
To gather information on the use of CorMatrix ECM for Vascular Repair in the reconstruction of the femoral artery.
Looking for future studies?
Notify MeAll sexes
Observational
OBJECTIVE The objective of the study is to actively gather additional information on the use of CorMatrix ECM for vascular repair in the reconstruction of the femoral artery. The CorMatrix ECM for Vascular Repair may be used for patch closure of vessels, as a pledget, or for suture line buttressing when repairing peripheral vessels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard femoral arterial interventional procedure using CorMatrix ECM for vascular repair.
Time frame: Up to 12 months follow-up
Proportion of patients experiencing device related adverse events.
Elutia Inc.
Industry
A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
Acronym: PERFORM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05107869
Cardiovascular Diseases, Endothelial Dysfunction
Wauwatosa, Wisconsin, United States
View Trial DetailsNCT03206762
Cardiovascular Diseases, Peripheral Vascular Disease
Davenport, Iowa, United States
View Trial DetailsNCT06112054
Cardiovascular Diseases, Peripheral Vascular Disease
Dendermonde, Belgium
View Trial DetailsNCT02685098
Amputation, Arterial Occlusive Disease
Indianapolis, Indiana, United States
View Trial Details